Changmao Biochemical Engineering Company Limited (00954) published its monthly return for the period ended 30 November 2025. The announcement shows that the total authorized share capital remained at RMB 52,970,000, consisting of 183,700,000 H shares, 2,500,000 domestic shares, and 343,500,000 foreign shares, with no increase or decrease recorded during the month.

The issued share structure also remained unchanged. H shares totaled 183,700,000, while domestic shares and foreign shares stood at 2,500,000 and 343,500,000, respectively. There were no outstanding share options, warrants, convertibles, or other agreements to issue shares in November 2025, and no treasury shares were reported.